drugset / Trial / NCT01043666
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to assess the efficacy and safety of YM178 in patients with symptoms of overactive bladder.
Timeline
- Start
- 2009-12-21
- Primary completion
- 2011-09-16
- Completion
- 2011-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | — | Oral |
| Subject | Tolterodine | Small molecule | — | Oral |